Profiling metastatic lesions from a pembro-refractory patient to reveal distinct genomic instabilities and non-uniform response to drug combinations, ex vivo

e18021Background: Tumor heterogeneity drives response or resistance to therapy. This is particularly true in cases of metastatic disease, in which distant tumors are governed by their unique microe...